ASPI - NASDAQ
ASP Isotopes Inc. Common Stock
$7.97
+5.6%ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
At a Glance
Live SnapshotASP Isotopes Inc. Common Stock Profit Bridge
Profitability Analysis
Gross Margin
Thin margins leave little room for error. Cost management and pricing strategy are critical.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
High margin compression: Large gap between gross and net margins suggests operational inefficiencies or heavy debt burden. Focus on expense management and deleveraging.
ASP Isotopes Inc. Common Stock Income Statement
ASPI • NASDAQ
| ASP Isotopes Inc. Common Stock Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2019 |
|---|---|---|---|---|---|---|
REVENUE | ||||||
23.8M | 4.1M | 433K | 0.0 | 0.0 | 22.6M | |
GROSS PROFIT | ||||||
(20.4M) | (2.5M) | (294.1K) | (0.0) | (19.4K) | (11.9M) | |
3.4M | 1.6M | 139K | 0.0 | -19.4K | 10.8M | |
OPERATING INCOME | ||||||
(60.6M) | (28M) | (16.2M) | (5.1M) | (2.6M) | (21.1M) | |
(48.2M) | (24.8M) | (15.4M) | (3.8M) | (2.5M) | (7M) | |
(12.4M) | (3.1M) | (764.6K) | (1.3M) | (41.6K) | (0.0) | |
-57.2M | -26.4M | -16M | -5.1M | -2.6M | -10.3M | |
PRE-TAX INCOME | ||||||
(575K) | (258.9K) | (118.5K) | (0.0) | (0.0) | (0.0) | |
6.2M | 979.8K | -109.5K | 3.4K | 115.0 | 8K | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (14.1M) | |
-102.4M | -6M | -258.3K | 153.9K | 113.0 | -104K | |
-159.6M | -32.3M | -16.3M | -4.9M | -2.6M | -10.4M | |
NET INCOME | ||||||
(282K) | (111.4K) | -6.1K | (0.0) | (0.0) | -104K | |
-175.1M | -32.3M | -16.3M | -4.9M | -2.6M | -10.3M |
SEC Filings
ASPI - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 26, 2026 | May 26, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 20, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 20, 2026 | May 20, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 11, 2026 | May 11, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 06, 2026 | May 06, 2026 | 2026 | |
10-K/A 10-K/A 2025 FY (Amended) FY | April 30, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | April 13, 2026 | April 13, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 10, 2026 | April 10, 2026 | 2026 | |
10-K 10-K 2025 FY FY | April 10, 2026 | December 31, 2025 | 2025 | |
8-K/A 8-K/A 2026 (Amended) N/A | March 24, 2026 | January 06, 2026 | 2026 |
Related Guides
Continue your ASPI research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.